UK trial has found that azathioprine does not slow progression in early Parkinson’s disease, despite good tolerability. The ...

Swiss biotech AC Immune has said that its vaccine-like alpha-synuclein-targeted immunotherapy has shown promise in slowing ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression. According to ...

Parkinson's disease represents a $6-8 billion market today, projected to exceed $13 billion by the 2030s, driven by rising ...

Researchers have identified a potential biomarker of Parkinson's disease progression. According to the new study, patients with a slow progression of the pathology would have a significant increase in ...

AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s DiseaseResults show, for the ...

How do you slow the progression of Parkinson’s disease? New studies suggest exercise, light therapy and a common cough medicine may help slow Parkinson’s disease progression and protect brain function ...

Prof. Chris Goetz, co-creator of the MDS-UPDRS, is a leading expert in movement disorder pharmacology and rating-scale development. He is a professor in the Department of Neurological Sciences and ...

Swiss clinical-stage biotech AC Immune today announced positive interim safety and efficacy results from the Phase II VacSYn ...